Rare blood clot incidents force Johnson & Johnson to pause the use of their vaccine in the U.S. where health officials have scrambled to reassure the public. The safety concerns also have implications for the rollout of the dose throughout the EU where it has been temporarily stopped just 24 hours since deliveries began. U.S. equities mostly shrug off the news, with the S&P 500 hitting record highs, buoyed in part by tech stocks. As earnings season begins, German software giant SAP reports preliminary Q1 profit jumping by a third, prompting the firm to raise its revenue guidance. Credit Suisse is reportedly unwinding its Archegos-linked positions, putting large blocks of Discovery shares on the market. In luxury news, LVMH has beaten Q1 expectations on rebounding Chinese and U.S. demand.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.